Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ABBOTT LABORATORIESABT · Entity 2314 | Director | March 31, 2009 | April 02, 2009 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ABBOTT LABORATORIES
Report date March 31, 2009 · Filed April 02, 2009
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock equivalent unitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 24,835 |
Reported balance
After 2009-03-31 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2009-03-31 · Grant · Acquired 314 · Balance 24,835 F1: Director fees credited to a stock equivalent unit account under a grantor trust established by him and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. |
Filing footnotes · ownership attribution and instrument terms
F1: Director fees credited to a stock equivalent unit account under a grantor trust established by him and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.
F2: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 31, 2009 Filed Apr 2, 2009 23:32 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantStock equivalent units · Derivative | 314 | $47.70 Strike: $0.00 | $14,977.80 |
DisclosureSEC source: 0001104659-09-022379 · a4.xml · derivative · entry 1 POWELL BOONE JR · CIK 0001232973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,835 Underlying: Common shares · 314 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by him and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by him and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by him and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| March 04, 2009 Filed Mar 5, 2009 22:21 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $46.24 | $4,624.25 |
DisclosureSEC source: 0001104659-09-014738 · a4.xml · nonDerivative · entry 5 POWELL BOONE JR · CIK 0001232973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,398 Read SEC document |
| March 04, 2009 Filed Mar 5, 2009 22:21 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,100 | $46.24 | $50,864.00 |
DisclosureSEC source: 0001104659-09-014738 · a4.xml · nonDerivative · entry 4 POWELL BOONE JR · CIK 0001232973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,498 Read SEC document |
| March 04, 2009 Filed Mar 5, 2009 22:21 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 794 | $46.23 | $36,706.62 |
DisclosureSEC source: 0001104659-09-014738 · a4.xml · nonDerivative · entry 3 POWELL BOONE JR · CIK 0001232973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,598 Read SEC document |
| March 04, 2009 Filed Mar 5, 2009 22:21 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,200 | $46.22 | $55,464.96 |
DisclosureSEC source: 0001104659-09-014738 · a4.xml · nonDerivative · entry 2 POWELL BOONE JR · CIK 0001232973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,392 Read SEC document |
| March 04, 2009 Filed Mar 5, 2009 22:21 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $46.22 | $4,622.02 |
DisclosureSEC source: 0001104659-09-014738 · a4.xml · nonDerivative · entry 1 POWELL BOONE JR · CIK 0001232973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,592 Read SEC document |
| December 31, 2008 Filed Jan 5, 2009 22:03 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantStock equivalent units · Derivative | 281 | $53.37 Strike: $0.00 | $14,996.97 |
DisclosureSEC source: 0001104659-09-000348 · a4.xml · derivative · entry 1 POWELL BOONE JR · CIK 0001232973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,361 Underlying: Common shares · 281 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by him and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by him and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by him and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| September 30, 2008 Filed Oct 2, 2008 21:02 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantStock equivalent units · Derivative | 260 | $57.58 Strike: $0.00 | $14,970.80 |
DisclosureSEC source: 0001104659-08-061717 · a4.xml · derivative · entry 4 POWELL BOONE JR · CIK 0001232973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,923 Underlying: Common shares · 260 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by him and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by him and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by him and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| June 30, 2008 Filed Jul 2, 2008 23:56 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantStock equivalent units · Derivative | 283 | $52.97 Strike: $0.00 | $14,990.51 |
DisclosureSEC source: 0001104659-08-043863 · a4.xml · derivative · entry 1 POWELL BOONE JR · CIK 0001232973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,521 Underlying: Common shares · 283 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by him and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by him and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by him and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| May 21, 2008 Filed Oct 2, 2008 21:02 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-08-061717 · a4.xml · nonDerivative · entry 1 POWELL BOONE JR · CIK 0001232973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,692 Read SEC document |
| April 25, 2008 Filed Apr 30, 2008 00:24 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 1,917 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-08-028090 · a4.xml · nonDerivative · entry 1 POWELL BOONE JR · CIK 0001232973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,692 F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the Board, dies, or the occurrence of a change in control (as defined in the Program). F1 · price: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the Board, dies, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| March 31, 2008 Filed Apr 2, 2008 22:29 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantStock equivalent units · Derivative | 271 | $55.15 Strike: $0.00 | $14,945.65 |
DisclosureSEC source: 0001104659-08-022154 · a4.xml · derivative · entry 1 POWELL BOONE JR · CIK 0001232973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,086 Underlying: Common shares · 271 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by him and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by him and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by him and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| December 31, 2007 Filed Jan 2, 2008 23:14 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantStock equivalent units · Derivative | 267 | $56.15 Strike: $0.00 | $14,992.05 |
DisclosureSEC source: 0001104659-08-000237 · a4.xml · derivative · entry 1 POWELL BOONE JR · CIK 0001232973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,680 Underlying: Common shares · 267 shares Expires not disclosed F1 · derivative.exercise_price: This director defers and credits director fees to a stock equivalent unit account under a grantor trust established by him and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: This director defers and credits director fees to a stock equivalent unit account under a grantor trust established by him and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: This director defers and credits director fees to a stock equivalent unit account under a grantor trust established by him and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| September 30, 2007 Filed Oct 3, 2007 00:19 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantStock equivalent units · Derivative | 279 | $53.62 Strike: $0.00 | $14,959.98 |
DisclosureSEC source: 0001104659-07-072706 · a4.xml · derivative · entry 1 POWELL BOONE JR · CIK 0001232973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,280 Underlying: common shares · 279 shares Expires not disclosed F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| June 30, 2007 Filed Jul 3, 2007 18:32 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantStock equivalent units · Derivative | 264 | $53.55 Strike: $0.00 | $14,137.20 |
DisclosureSEC source: 0001104659-07-052112 · a4.xml · derivative · entry 1 POWELL BOONE JR · CIK 0001232973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,865 Underlying: common shares · 264 shares Expires not disclosed F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| April 27, 2007 Filed May 1, 2007 22:14 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 1,730 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-07-034472 · a4.xml · nonDerivative · entry 1 POWELL BOONE JR · CIK 0001232973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,775 F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the board, dies, or the occurrence of a change in control (as defined in the Program). F1 · price: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the board, dies, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| March 31, 2007 Filed Apr 3, 2007 19:57 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantStock equivalent units · Derivative | 224 | $55.80 Strike: $0.00 | $12,499.20 |
DisclosureSEC source: 0001104659-07-025425 · a4.xml · derivative · entry 1 POWELL BOONE JR · CIK 0001232973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,481 Underlying: common shares · 224 shares Expires not disclosed F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| December 31, 2006 Filed Jan 3, 2007 21:25 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantStock equivalent units · Derivative | 256 | $48.71 Strike: $0.00 | $12,469.76 |
DisclosureSEC source: 0001104659-07-000378 · a4.xml · derivative · entry 1 POWELL BOONE JR · CIK 0001232973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,139 Underlying: common shares · 256 shares Expires not disclosed F1 · derivative.exercise_price: This director defers and credits director fees to a stock equivalent unit account under a grantor trust established by him and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: This director defers and credits director fees to a stock equivalent unit account under a grantor trust established by him and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: This director defers and credits director fees to a stock equivalent unit account under a grantor trust established by him and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| September 30, 2006 Filed Oct 3, 2006 20:59 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantStock equivalent units · Derivative | 257 | $48.56 Strike: $0.00 | $12,479.92 |
DisclosureSEC source: 0001104659-06-064638 · a4.xml · derivative · entry 1 POWELL BOONE JR · CIK 0001232973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,752 Underlying: common shares · 257 shares Expires not disclosed F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| September 14, 2006 Filed Sep 15, 2006 21:00 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,000 | $49.10 | $49,100.00 |
DisclosureSEC source: 0001104659-06-061447 · a4.xml · nonDerivative · entry 1 POWELL BOONE JR · CIK 0001232973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,045 Read SEC document |
| June 30, 2006 Filed Jul 5, 2006 22:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantStock equivalent units · Derivative | 286 | $43.61 Strike: $0.00 | $12,472.46 |
DisclosureSEC source: 0001104659-06-045421 · a4.xml · derivative · entry 1 POWELL BOONE JR · CIK 0001232973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,371 Underlying: common shares · 286 shares Expires not disclosed F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| May 08, 2006 Filed May 10, 2006 19:32 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Salecommon shares without par value | 1,798 | $42.37 | $76,181.26 |
DisclosureSEC source: 0001104659-06-033230 · a4.xml · nonDerivative · entry 3 POWELL BOONE JR · CIK 0001232973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,045 Read SEC document |
| May 08, 2006 Filed May 10, 2006 19:32 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Salecommon shares without par value | 3,100 | $42.36 | $131,316.00 |
DisclosureSEC source: 0001104659-06-033230 · a4.xml · nonDerivative · entry 2 POWELL BOONE JR · CIK 0001232973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,843 Read SEC document |
| May 08, 2006 Filed May 10, 2006 19:32 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Salecommon shares without par value | 1,100 | $42.35 | $46,585.00 |
DisclosureSEC source: 0001104659-06-033230 · a4.xml · nonDerivative · entry 1 POWELL BOONE JR · CIK 0001232973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,943 Read SEC document |
| April 28, 2006 Filed May 2, 2006 21:35 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 2,127 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-06-030325 · a4.xml · nonDerivative · entry 1 POWELL BOONE JR · CIK 0001232973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,043 F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the Board, dies, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| March 31, 2006 Filed Apr 4, 2006 18:46 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantStock equivalent units · Derivative | 294 | $42.46 Strike: $0.00 | $12,483.24 |
DisclosureSEC source: 0001104659-06-022089 · a4.xml · derivative · entry 1 POWELL BOONE JR · CIK 0001232973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,938 Underlying: common shares · 294 shares Expires not disclosed F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| December 31, 2005 Filed Jan 4, 2006 20:57 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantStock equivalent units · Derivative | 317 | $39.43 Strike: $0.00 | $12,499.31 |
DisclosureSEC source: 0001104659-06-000353 · a4.xml · derivative · entry 1 POWELL BOONE JR · CIK 0001232973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,529 Underlying: common shares · 317 shares Expires not disclosed F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| December 01, 2005 Filed Dec 2, 2005 00:01 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Salecommon shares without par value | 2,130 | $37.54 | $79,960.20 |
DisclosureSEC source: 0001104659-05-058650 · a4.xml · nonDerivative · entry 1 POWELL BOONE JR · CIK 0001232973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,916 Read SEC document |
| September 30, 2005 Filed Oct 3, 2005 23:25 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantStock equivalent units · Derivative | 294 | $42.40 Strike: $0.00 | $12,465.60 |
DisclosureSEC source: 0001104659-05-046913 · a4.xml · derivative · entry 1 POWELL BOONE JR · CIK 0001232973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,086 Underlying: common shares · 294 shares Expires not disclosed F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| June 30, 2005 Filed Jul 1, 2005 19:05 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantStock equivalent units · Derivative | 255 | $49.01 Strike: $0.00 | $12,497.55 |
DisclosureSEC source: 0001104659-05-030982 · a4.xml · derivative · entry 1 POWELL BOONE JR · CIK 0001232973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,680 Underlying: common shares · 255 shares Expires not disclosed F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| April 22, 2005 Filed Apr 26, 2005 21:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 1,889 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-05-018231 · a4.xml · nonDerivative · entry 1 POWELL BOONE JR · CIK 0001232973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,046 F1 · shares: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the Board, dies, or the occurrence of a change in control (as defined the Program). Read SEC document |
| March 31, 2005 Filed Apr 4, 2005 20:23 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantStock equivalent units · Derivative | 268 | $46.62 Strike: $0.00 | $12,494.16 |
DisclosureSEC source: 0001104659-05-014996 · a4.xml · derivative · entry 1 POWELL BOONE JR · CIK 0001232973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,322 Underlying: common shares · 268 shares Expires not disclosed F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| December 31, 2004 Filed Jan 4, 2005 19:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantStock equivalent units · Derivative | 267 | $46.65 Strike: $0.00 | $12,455.55 |
DisclosureSEC source: 0001104659-05-000222 · a4.xml · derivative · entry 4 POWELL BOONE JR · CIK 0001232973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,954 Underlying: common shares · 267 shares Expires not disclosed F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| December 17, 2004 Filed Jan 4, 2005 19:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 550 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-05-000222 · a4.xml · nonDerivative · entry 1 POWELL BOONE JR · CIK 0001232973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,157 Read SEC document |
| September 30, 2004 Filed Oct 4, 2004 20:00 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantStock equivalent units · Derivative | 295 | $42.36 Strike: $0.00 | $12,496.20 |
DisclosureSEC source: 0001104659-04-029505 · a4.xml · derivative · entry 1 POWELL BOONE JR · CIK 0001232973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,583 Underlying: common shares · 295 shares Expires not disclosed F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| June 30, 2004 Filed Jul 1, 2004 23:32 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantStock equivalent units · Derivative | 306 | $40.76 Strike: $0.00 | $12,472.56 |
DisclosureSEC source: 0001104659-04-018805 · a4.xml · derivative · entry 1 POWELL BOONE JR · CIK 0001232973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,175 Underlying: common shares · 306 shares Expires not disclosed F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| May 03, 2004 Filed May 5, 2004 22:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantStock equivalent units · Derivative | 4,442 | $42.32 Strike: $0.00 | $187,985.44 |
DisclosureSEC source: 0001104659-04-012717 · a4.xml · derivative · entry 1 POWELL BOONE JR · CIK 0001232973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,791 Underlying: common shares · 4,442 shares Expires not disclosed F1 · derivative.exercise_price: A stock equivalent unit account is maintained for the director for the deferral of director fees. These additional stock equivalent units were credited to that account. They resulted from the conversion into stock equivalent units of the deemed distribution of Hospira common stock, in connection with the spin-off of Hospira, Inc. from Abbott, based on the closing price of Abbott and Hospira common stock on May 3, 2004. Units are paid in cash. F1 · derivative.exercise_date: A stock equivalent unit account is maintained for the director for the deferral of director fees. These additional stock equivalent units were credited to that account. They resulted from the conversion into stock equivalent units of the deemed distribution of Hospira common stock, in connection with the spin-off of Hospira, Inc. from Abbott, based on the closing price of Abbott and Hospira common stock on May 3, 2004. Units are paid in cash. F1 · derivative.expiration_date: A stock equivalent unit account is maintained for the director for the deferral of director fees. These additional stock equivalent units were credited to that account. They resulted from the conversion into stock equivalent units of the deemed distribution of Hospira common stock, in connection with the spin-off of Hospira, Inc. from Abbott, based on the closing price of Abbott and Hospira common stock on May 3, 2004. Units are paid in cash. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| April 23, 2004 Filed Apr 27, 2004 19:07 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 1,577 | $41.20 | $64,972.40 |
DisclosureSEC source: 0001104659-04-011392 · a4.xml · nonDerivative · entry 1 POWELL BOONE JR · CIK 0001232973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,707 F1 · kind: These shares represent a restricted stock award under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| March 31, 2004 Filed Apr 1, 2004 23:09 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantStock equivalent units · Derivative | 303 | $41.16 Strike: $0.00 | $12,471.48 |
DisclosureSEC source: 0001104659-04-009237 · a4.xml · derivative · entry 1 POWELL BOONE JR · CIK 0001232973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,348 Underlying: common shares · 303 shares Expires not disclosed F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| December 31, 2003 Filed Jan 2, 2004 18:07 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantStock equivalent units · Derivative | 268 | $46.60 Strike: $0.00 | $12,488.80 |
DisclosureSEC source: 0001104659-04-000020 · a4.xml · derivative · entry 1 POWELL BOONE JR · CIK 0001232973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,978 Underlying: common shares · 268 shares Expires not disclosed F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| September 30, 2003 Filed Oct 1, 2003 22:22 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantStock equivalent units · Derivative | 293 | $42.55 Strike: $0.00 | $12,467.15 |
DisclosureSEC source: 0001104659-03-021926 · a4.xml · derivative · entry 1 POWELL BOONE JR · CIK 0001232973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,646 Underlying: common shares · 293 shares Expires not disclosed F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| June 30, 2003 Filed Jul 2, 2003 19:02 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantStock equivalent unit · Derivative | 285 | $43.76 Strike: $0.00 | $12,471.60 |
DisclosureSEC source: 0001104659-03-013880 · j2755_4.xml · derivative · entry 1 POWELL BOONE JR · CIK 0001232973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,282 Underlying: Common shares · 285 shares Expires 1988-08-08 F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a divided reinvestment feature. Read SEC document |
| July 21, 2000 Filed Feb 13, 2004 20:14 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Giftcommon shares without par value | 30 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-04-004265 · a4.xml · nonDerivative · entry 1 POWELL BOONE JR · CIK 0001232973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,130 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.